Using electrical stimulation to improve blood flow and trunk control in spinal cord injury patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HemON study evaluates the safety and preliminary efficacy of ARC-IM Therapy, which involves the implantation of an investigational system for epidural electrical stimulation. This therapy aims to enhance hemodynamic management and trunk control in individuals with sub-acute or chronic spinal cord injuries, specifically those experiencing orthostatic hypotension. Participants must have sustained a spinal cord injury between the C3 and T6 vertebrae and be at least one month post-injury. The study will assess the impact of this intervention on their overall stability and control.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Must provide and sign the Informed Consent prior to any study related procedures
* Spinal cord injury lesion level between C3 and T6 (inclusive)
* SCI ≥ 1month
* Confirmed orthostatic hypotension
* Stable medical, physical and psychological condition as considered by the investigators
* Able to understand and interact with the study team in French or English
* Agrees to comply in good faith with all conditions of the study and to attend all scheduled appointments

Exclusion Criteria:

* SCI related to a neurodegenerative disease
* Diseases and conditions that would increase the morbidity and mortality of spinal cord injury surgery
* The inability to withhold antiplatelet/anticoagulation agents perioperatively
* History of myocardial infarction or cerebrovascular event within the past 6 months
* Other conditions that would make the subject unable to participate in testing in the judgement of the investigators
* Clinically significant mental illness in the judgement of the investigators
* Botulinum toxin vesical and non-vesical injections in the previous 3 months before the enrolment
* Presence of significant pressure ulcers
* Recurrent urinary tract infection refractory to antibiotics
* Presence of indwelling baclofen or insulin pump
* Women who are pregnant (pregnancy test obligatory for woman of childbearing potential) or breast feeding,
* Lack of safe contraception for women of childbearing capacity,
* Intention to become pregnant during the course of the study,
* Other clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.),
* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders or dementia of the participant,
* Participation in another study with investigational drug within the 30 days preceding and during the present study,
* Enrolment of the investigator, his/her family members, employees, and other dependent persons.

Where it's running

• Chuv
  Lausanne, Canton of Vaud, Switzerland Recruiting

Study contacts

• Principal investigator: Jocelyne Bloch, MD — Chuv
• Study coordinator: Gregoire Courtine, Prof
• Email: gregoire.courtine@epfl.ch
• Phone: +41 21 69 30762

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury

  This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.

  Recruiting TryAbility LLC · Downers Grove, Illinois · NCT07922122

• NG004 for incomplete cervical spinal cord injury

  This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.

  Recruiting at 7 sites Phase 1 NovaGo Therapeutics AG · Bayreuth and 9 other locations · NCT07840196

• Robot-assisted training for arm and leg movement after stroke or injury

  This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.

  Recruiting Bangladesh Medical University · Dhaka · NCT07749625

• ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab

  This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.

  Recruiting Bangladesh Medical University · Dhaka, Dhaka Division · NCT07705906

• Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury

  This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.

  Recruiting Shengjing Hospital · Shenyang · NCT07704268

• Hybrid HIIT-FES cycling program for people with spinal cord injury

  This study tests a hybrid exercise program that combines functional electrical stimulation cycling with voluntary arm work to improve health in adults with spinal cord injury.

  Recruiting William Carey University · Hattiesburg, Mississippi · NCT07648173

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.